AIDS WEEKLY Plus - October 2005Important note: Information in this article was accurate in October 2005. The state of the art may have changed since the publication date.
Click here to return to AIDS WEEKLY PLUS main menu

DonateNow
Print this Article

HIV/AIDS Immunity: Low-level antigen exposure is sufficient for sustained HIV-specific immunity

AIDSWEEKLY Plus; Monday, October 24, 2005
Staff Medical Writers


NewsRx -- Low-level antigen exposure is sufficient for sustained HIV-specific immunity.

According to a study from the Netherlands, "Long-term nonprogressive HIV infection, characterized by low but detectable viral load and stable CD4 counts in the absence of antiviral therapy, is observed in about 5% of HIV-infected patients.

"Here we identified four therapy naïve individuals who are strongly seropositive for HIV-1 but who lack evidence of detectable HIV p24 antigen, plasma RNA, and proviral DNA in routine diagnostic testing."

"With an ultrasensitive PCR, we established that frequencies of pol proviral DNA sequences were as low as 0.2-0.5 copies/106 PBMC. HIV could not be isolated using up to 30x106 patient PBMC," reported N. Kloosterboer and colleagues at the University of Amsterdam.

"One individual was heterozygous for CCR5 Delta 32, but CCR5 expression on CD4+ T cells was normal to high in all four individuals. In vitro R5 and X4 HIV-1 susceptibility of CD8-depleted PBMC of all study subjects was significantly lower than the susceptibility of CD8-depleted PBMC of healthy blood donors.

"All individuals expressed protective HLA-B*58s alleles and showed evidence of HIV-specific cellular immunity either by staining with HLA-B*57 tetramers folded with an HIV RT or gag peptide or after stimulation with HIV-1 p24 gag, RT, or nef peptides in ELIspot analysis," scientists said.

The authors continued, "HIV-specific CD4+ T helper cells were demonstrated by proliferation of CD4+ T cells and intracellular staining for IL-2 and IFN gamma after stimulation with an HIV-gag peptide pool. Sera of all individuals showed antibody-mediated neutralization of both R5 and X4 HIV-1 variants."

"These data implicate that very low-level antigen exposure is sufficient for sustained HIV-specific immunity and suggest the possibility of a multifactorial control of HIV infection," Kloosterboer concluded.

Kloosterboer and colleagues published the results of their research in Virology (Natural controlled HIV infection: Preserved HIV-specific immunity despite undetectable replication competent virus. Virology. 2005 Aug 15;339(1):70-80.

For additional information, contact H. Schuitemaker, University of Amsterdam, CLB, Sanquin Research, Plesmanlaan 125, NL-1066 CX Amsterdam, Netherlands.

The publisher of the journal Virology can be contacted at: Academic Press Inc. Elsevier Science, 525 B St., Ste. 1900, San Diego, CA 92101-4495, USA.

Keywords: CX Amsterdam, Netherlands, HIV/AIDS, Antigen Exposure, Virus-Specific Immunity, Viral Replication, CD4 Cells, Antiviral Therapy.

This article was prepared by AIDS Weekly editors from staff and other reports.

Reference

Kloosterboer N, Groeneveld PH, Jansen CA, et al. Natural controlled HIV infection: preserved HIV-specific immunity despite undetectable replication competent virus, Virology. 2005 Aug 15;339(1):70-80.

PubMED Related articles Search

051024
AW051011


Copyright © 2005 - Charles Henderson, Publisher. All rights Reserved. Permission to reproduce granted to AEGIS by Charles W. Henderson. Authorization to reproduce for personal use granted granted by C. W. Henderson, Publisher, provided that the fee of US$4.50 per copy, per page is paid directly to the Copyright Clearance Center, 27 Congress Street, Salem, Massachusetts 01970, USA. Published by Charles Henderson, Publisher. Editorial & Publishing Office: P.O. Box 5528, Atlanta, GA 30307-0528 / Telephone: (800) 633-4931; Subscription Office: P.O. Box 830409, Birmingham, AL 35283-0409 / FAX: (205) 995-1588 http://www.newsrx.net

AEGiS is made possible through unrestricted grants from Boehringer Ingelheim, Elton John AIDS Foundation, Bridgestone/Firestone Charitable Trust, the National Library of Medicine, and donations from users like you. Always watch for outdated information. This article first appeared in 2005. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright © 1980,2005. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content.